Letters Data openness

Don’t forget preclinical science

BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c6324 (Published 09 November 2010) Cite this as: BMJ 2010;341:c6324
  1. Andrew J Goudie, reader in psychopharmacology1
  1. 1School of Psychology, Eleanor Rathbone Building, Liverpool University, L69 3BX, UK
  1. ajg{at}liverpool.ac.uk

During the 1990s the pharmaceutical industry developed various atypical antipsychotic drugs that were contrasted favourably with older typical antipsychotics. Recent independent trials and meta-analyses indicate that the effects of the atypicals were exaggerated and that the existence of the drugs as a class is spurious, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe